A novel cancer immunotherapy boosts immune response and enhances tumor susceptibility

Now in clinical trials, the new dual-action molecule being tested by researchers greatly increases the patient responses to immunotherapy

Image Credit: MidjourneyAI

PD-1 inhibitors are groundbreaking drugs in the realm of cancer immunotherapy. They work by blocking the PD-1 checkpoint protein, which cancer cells exploit to evade the immune system. By inhibiting PD-1, these drugs unleash the immune system's full potential, allowing it to recognize and target cancer cells effectively. This a…